(Q46195926)

20 December 2017

title

High impact of FDG-PET/CT in diagnostic strategies for ovarian cancer (English)

1 reference

20 December 2017

1 reference

Ashraf Anas Zytoon

1

1 reference

20 December 2017

Koji Murakami

series ordinal

2

1 reference

20 December 2017

Hazem Eid

series ordinal

3

1 reference

20 December 2017

Mahmoud El-Gammal

series ordinal

4

1 reference

20 December 2017

language of work or name

English

0 references

publication date

14 January 2013

1 reference

20 December 2017

published in

Acta Radiologica

1 reference

20 December 2017

volume

54

1 reference

20 December 2017

issue

3

1 reference

20 December 2017

page(s)

340-348

1 reference

20 December 2017

The CA 125 tumour-associated antigen: a review of the literature

cites work

1 reference

https://api.crossref.org/works/10.1258%2FAR.2012.120632

Role of CT and MR imaging in predicting optimal cytoreduction of newly diagnosed primary epithelial ovarian cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FAR.2012.120632

Positron emission tomography imaging for gynecologic malignancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FAR.2012.120632

Asymptomatic adnexal masses: correlation of FDG PET and histopathologic findings

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FAR.2012.120632

Clinical applications of PET in oncology

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FAR.2012.120632

Incremental benefits of FDG positron emission tomography over CT alone for the preoperative staging of ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FAR.2012.120632

Physiological 18F-FDG uptake in the ovaries and uterus of healthy female volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FAR.2012.120632

Accuracy of integrated FDG-PET/contrast-enhanced CT in detecting pelvic and paraaortic lymph node metastasis in patients with uterine cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FAR.2012.120632

Comparison of the accuracy of magnetic resonance imaging and positron emission tomography/computed tomography in the presurgical detection of lymph node metastases in patients with uterine cervical carcinoma: a prospective study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FAR.2012.120632

Lymph node metastasis in patients with clinical early-stage cervical cancer: detection with integrated FDG PET/CT.

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FAR.2012.120632

The diagnostic value of PET/CT scanning in patients with cervical cancer: a prospective study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FAR.2012.120632

Experience with positron emission tomography (PET) scans in patients with ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FAR.2012.120632

Whole-body positron emission tomography with 2-[18F]-fluoro-2-deoxy-D-glucose can detect recurrent ovarian carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FAR.2012.120632

Borderline ovarian tumors in Sweden 1960-2005: trends in incidence and age at diagnosis compared to ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FAR.2012.120632

The diagnostic value of PET/CT for primary ovarian cancer--a prospective study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FAR.2012.120632

The diagnostic accuracy of 18F-fluorodeoxyglucose PET/CT in patients with gynecological malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FAR.2012.120632

Whole-body positron emission tomography and positron emission tomography/computed tomography in gynecologic oncology

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FAR.2012.120632

Post-therapy surveillance of patients with uterine cancers: value of integrated FDG PET/CT in the detection of recurrence.

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FAR.2012.120632

Clinically occult recurrent ovarian cancer: patient selection for secondary cytoreductive surgery using combined PET/CT.

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FAR.2012.120632

Clinical value of positron emission tomography with FDG for recurrent ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FAR.2012.120632

2-[Fluorine-18]-fluoro-2-deoxy-d-glucose positron emission tomography in the diagnosis of recurrent ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FAR.2012.120632

Usefulness of FDG PET for assessment of early recurrent epithelial ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FAR.2012.120632

Oncological diagnosis using positron coincidence gamma camera with fluorodeoxyglucose in comparison with dedicated PET.

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FAR.2012.120632

Comparison of the validity of magnetic resonance imaging and positron emission tomography/computed tomography in the preoperative evaluation of patients with uterine corpus cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1258%2FAR.2012.120632

21 January 2018

Identifiers

DOI

10.1258/AR.2012.120632

1 reference

20 December 2017

1 reference

20 December 2017